ArticleBreast cancer research and treatment2025
Factors associated with receipt of surveillance breast MRI among racially and ethnically diverse women with operable breast cancer.
Article in Breast cancer research and treatment, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Racial disparities in breast cancer subtypes, recurrence, and survival: a longitudinal cohort analysis.Frontiers in oncology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
purposeDue to increased sensitivity for early detection compared to mammography, breast MRI is increasingly used for surveillance screening in women with breast cancer, especially in those diagnosed at a young age or with dense breasts. We investigated factors associated with receipt of breast MRI in women with operable breast cancer.
methodsOur cohort included women with stage 0-III breast cancer seen at an urban academic medical center from January 2018 to June 2023. We collected demographic and clinical data from the electronic health record. The primary endpoint was receipt of surveillance breast MRI > 1 year after diagnosis. Multivariable logistic regression was used to identify factors associated with breast MRI use.
resultsAmong 1989 racially/ethnically diverse women, a total of 355 (17.8%) women received at least one surveillance breast MRI. In multivariable analysis, Hispanic and non-Hispanic Black women were less likely to receive surveillance breast MRI than non-Hispanic White women (odds ratio [OR] = 0.44, 95% confidence interval [CI] = 0.31-0.63 and OR = 0.57, 95% CI = 0.38-0.86, respectively). However, compared to women with commercial insurance, women with Medicaid were more likely to receive surveillance breast MRI (OR = 1.57, 95% CI = 1.10-2.25). Results were similar when restricting to women diagnosed under age 50 or with dense breasts. Receipt of breast MRI was associated with smaller breast tumor size at recurrence (p = 0.016). Among women who received breast MRI, 22.5% had a false-positive biopsy compared with 11.5% of women who received mammography alone (p < 0.001).
conclusionReceipt of breast MRI among breast cancer survivors differed by race, ethnicity, and insurance payor mix. These disparities in the use of breast MRI highlight the need for more standardized guidelines surrounding the optimal role of surveillance breast MRI among women with breast cancer, which can inform targeted public health interventions aimed at promoting more equitable screening practices in this population.
Indexed as
Identifiers
41348256What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.